Form D · Pharmaceuticals
ST RENATUS LLC
Ft Collins, CO · CIK 0001433959
Offering snapshot reported Jun 22, 2018 · SEC filing
- Reported sold
- Yet to sell Offering amount: $26M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25.1K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 22, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 27, 2017 | Initial | $1,060,000 | No comparison | 6 | SEC filing |
| Sep 3, 2014 | Initial | $65,000 | No comparison | 1 | SEC filing |
| Jan 7, 2014 | Initial | $66,300 | No comparison | 3 | SEC filing |
| Dec 14, 2012 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Jun 20, 2012 | Initial | $40,000 | No comparison | 1 | SEC filing |
| Apr 4, 2012 | Amendment | $5,828,830 | $5,649,840vs Jun 16, 2011 | 124 | SEC filing |
| Jun 16, 2011 | Initial | $178,990 | No comparison | 1 | SEC filing |
| Nov 25, 2009 | Initial | $141,750 | No comparison | 2 | SEC filing |
| May 5, 2009 | Initial | $110,000 | No comparison | Not reported | SEC filing |
| Apr 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-315203
Source: Form D, filed Jun 22, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Clifford M. Buchholz | Executive |
| Martin A. Culhane | Director |
| Martin A. Culhane Iii | Executive |
| Ronald W. Hart | Director, Executive |
| Kurt Hoeven | Director |
| Brent M T Keele | Director |
| Mark D. Kollar | Director |
| Eric Lodewijk | Director |
| Steven T. Merrick | Executive |
| Steve T. Merrick | Director, Executive |
| Jerry M Morgensen | Director |
| James P. Mulvahill | Director |
| James L Parke | Director |
| Frank R Ramirez | Director, Executive |
| Joesph D Schofield Iii | Director |
| Christopher M. Scotti | Director |
| Jill M. Shoemaker | Executive |
| Paul Sletten | Executive |
| Steve Snyder | Director |
| Stephen D Tebo | Director |
| Terence M Tucker | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1000 Centre Avenue
Ft Collins, CO, 80526
Ft Collins, CO, 80526